Receive $200 for creating an Interactive Brokers account using our link: Create IBKR account. Read our Interactive Brokers analysis

Ticker
MDGL

Price
498.04
Stock movement up
+1.07 (0.22%)
Company name
Madrigal Pharmaceuticals Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
11.31B
Ent value
11.75B
Price/Sales
15.27
Price/Book
18.08
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
204.20
PEG
-
EPS growth
32.06%
1 year return (CAGR)
62.19%
3 year return (CAGR)
-
5 year return (CAGR)
-
10 year return (CAGR)
-
Last updated: 2026-01-22

DIVIDENDS

MDGL does not pay dividends or no data was received

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales15.27
Price to Book18.08
EV to Sales15.87

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count22.71M
EPS (TTM)-12.86
FCF per share (TTM)-7.19

Income statement

Loading...
Income statement data
Revenue (TTM)740.64M
Gross profit (TTM)705.12M
Operating income (TTM)-307.48M
Net income (TTM)-289.13M
EPS (TTM)-12.86
EPS (1y forward)2.44

Margins

Loading...
Margins data
Gross margin (TTM)95.20%
Operating margin (TTM)-41.52%
Profit margin (TTM)-39.04%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash295.69M
Net receivables113.28M
Total current assets1.35B
Goodwill0.00
Intangible assets7.48M
Property, plant and equipment8.30M
Total assets1.36B
Accounts payable44.94M
Short/Current long term debt346.40M
Total current liabilities391.41M
Total liabilities736.73M
Shareholder's equity625.73M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-160.58M
Capital expenditures (TTM)1.05M
Free cash flow (TTM)-161.63M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-46.21%
Return on Assets-21.22%
Return on Invested Capital-29.91%
Cash Return on Invested Capital-16.72%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open496.97
Daily high504.00
Daily low492.01
Daily Volume221K
All-time high602.83
1y analyst estimate603.47
Beta-1.05
EPS (TTM)-12.86
Dividend per share0.00
Ex-div date-
Next earnings date4 Mar 2026

Downside potential

Loading...
Downside potential data
MDGLS&P500
Current price drop from All-time high-17.38%-0.89%
Highest price drop-50.60%-19.00%
Date of highest drop23 Oct 20248 Apr 2025
Avg drop from high-18.09%-2.49%
Avg time to new high18 days6 days
Max time to new high217 days89 days
COMPANY DETAILS
MDGL (Madrigal Pharmaceuticals Inc) company logo
Marketcap
11.31B
Marketcap category
Large-cap
Description
Madrigal Pharmaceuticals, Inc., a biopharmaceutical company, focuses on delivering novel therapeutics for metabolic dysfunction-associated steatohepatitis (MASH) in the United States. It offers Rezdiffra, a liver-directed thyroid hormone receptor beta agonist for treating MASH. The company is headquartered in West Conshohocken, Pennsylvania.
Employees
528
Investor relations
-
SEC filings
CEO
Paul A. Friedman
Country
USA
City
West Conshohocken
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...